DK145381C - Fremgangsmaade til fremstilling af et antibiotisk stof,kaldet n-acetyldehydrothienamycin,eller farmaceutisk acceptable salte deraf - Google Patents

Fremgangsmaade til fremstilling af et antibiotisk stof,kaldet n-acetyldehydrothienamycin,eller farmaceutisk acceptable salte deraf

Info

Publication number
DK145381C
DK145381C DK150278A DK150278A DK145381C DK 145381 C DK145381 C DK 145381C DK 150278 A DK150278 A DK 150278A DK 150278 A DK150278 A DK 150278A DK 145381 C DK145381 C DK 145381C
Authority
DK
Denmark
Prior art keywords
acetyldehydrothienamycine
procedure
called
preparation
acceptable salts
Prior art date
Application number
DK150278A
Other languages
Danish (da)
English (en)
Other versions
DK145381B (da
DK150278A (da
Inventor
J S Kahan
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK150278A publication Critical patent/DK150278A/da
Publication of DK145381B publication Critical patent/DK145381B/da
Application granted granted Critical
Publication of DK145381C publication Critical patent/DK145381C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK150278A 1977-04-18 1978-04-05 Fremgangsmaade til fremstilling af et antibiotisk stof,kaldet n-acetyldehydrothienamycin,eller farmaceutisk acceptable salte deraf DK145381C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/788,491 US4162323A (en) 1977-04-18 1977-04-18 Antibiotic N-acetyl-dehydro-thienamycin
US78849177 1977-04-18

Publications (3)

Publication Number Publication Date
DK150278A DK150278A (da) 1979-02-08
DK145381B DK145381B (da) 1982-11-08
DK145381C true DK145381C (da) 1983-04-11

Family

ID=25144652

Family Applications (1)

Application Number Title Priority Date Filing Date
DK150278A DK145381C (da) 1977-04-18 1978-04-05 Fremgangsmaade til fremstilling af et antibiotisk stof,kaldet n-acetyldehydrothienamycin,eller farmaceutisk acceptable salte deraf

Country Status (15)

Country Link
US (1) US4162323A (ja)
JP (1) JPS53130494A (ja)
BE (1) BE866035A (ja)
CH (1) CH640237A5 (ja)
DE (1) DE2816608A1 (ja)
DK (1) DK145381C (ja)
ES (1) ES468739A1 (ja)
FR (1) FR2387984A1 (ja)
GB (1) GB1584228A (ja)
IE (1) IE46719B1 (ja)
IT (1) IT1104845B (ja)
LU (1) LU79452A1 (ja)
NL (1) NL7803623A (ja)
PT (1) PT67884B (ja)
SE (1) SE7803846L (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2654146C2 (de) * 1976-11-30 1982-04-01 Standard Elektrik Lorenz Ag, 7000 Stuttgart Einrichtung für ein Prüfgerät
GR62185B (en) * 1977-03-31 1979-03-02 Panlabs Inc Preparation process of an antibiotic ps-5 and its derivatives with inhibitory activity of b-lactamase
EP0007152A1 (en) * 1978-04-28 1980-01-23 Beecham Group Plc Beta-lactam antibiotics, preparation and use
DE2963717D1 (en) * 1978-05-06 1982-11-04 Beecham Group Plc Carbapenem derivatives, a process for their preparation and pharmaceutical compositions containing them
NZ190994A (en) 1978-07-24 1981-10-19 Merck & Co Inc Z-2-acylamino-3-monosubstituted propenoates
US4446146A (en) * 1978-07-26 1984-05-01 Beecham Group Limited β-Lactam containing compounds, their preparation and use
DE2963580D1 (en) * 1978-08-02 1982-10-21 Beecham Group Plc Beta-lactam antibacterial agents, a process for their preparation and pharmaceutical compositions containing them
DE2966446D1 (en) * 1978-09-09 1984-01-05 Beecham Group Plc Beta-lactam compounds, their preparation and use
US4409147A (en) * 1980-03-10 1983-10-11 Takeda Chemical Industries, Ltd. Carbapenem compounds and their production
JPS57109786A (en) * 1980-12-26 1982-07-08 Takeda Chem Ind Ltd Antibiotic c-19393e5 and its preparation
US10629978B2 (en) 2017-10-30 2020-04-21 International Business Machines Corporation Multi-path interferometric Josephson isolator based on nondegenerate three-wave mixing Josephson devices
US10262275B1 (en) 2017-12-01 2019-04-16 International Business Machines Corporation Selective switching of frequency multiplexed microwave signals using cascading multi-path interferometric Josephson switches with nonoverlapping bandwidths
US10396732B2 (en) 2017-12-01 2019-08-27 International Business Machines Corporation Amplification of frequency multiplexed microwave signals using cascading multi-path interferometric josephson directional amplifiers with nonoverlapping bandwidths
US10396731B2 (en) 2017-12-01 2019-08-27 International Business Machines Corporation Selective amplification of frequency multiplexed microwave signals using cascading multi-path interferometric Josephson directional amplifiers with nonoverlapping bandwidths
US10311379B1 (en) 2017-12-01 2019-06-04 International Business Machines Corporation Isolation of frequency multiplexed microwave signals using cascading multi-path interferometric josephson isolators with nonoverlapping bandwidths
US10169722B1 (en) 2017-12-01 2019-01-01 International Business Machines Corporation Selective isolation of frequency multiplexed microwave signals using cascading multi-path interferometric josephson isolators with nonoverlapping bandwidths
US10511072B2 (en) 2017-12-01 2019-12-17 International Business Machines Corporation Switching of frequency multiplexed microwave signals using cascading multi-path interferometric Josephson switches with nonoverlapping bandwidths

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics
DK143713C (da) * 1975-11-21 1982-03-08 Merck & Co Inc Fremgangsmaade til fremstilling af et antibiotisk stof n-acetyl-thienamycin og salte deraf
DK143712C (da) * 1975-11-21 1982-03-22 Merck & Co Inc Fremgangsmaade til fremstilling af de antibiotiske stoffer 890a1 og 890a3
NL7704040A (nl) * 1976-04-28 1977-11-01 Merck & Co Inc Werkwijze voor het bereiden van nieuwe anti- biotica.
DE2808563A1 (de) * 1977-03-05 1978-09-07 Beecham Group Ltd Derivate der 3-thio-6-(1-hydroxyaethyl)-7-oxo-1-aza-bicyclo eckige klammer auf 3.2.0 eckige klammer zu hept-2-en- 2-carbonsaeure, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
IE780725L (en) 1978-10-18
DK145381B (da) 1982-11-08
BE866035A (fr) 1978-10-17
ES468739A1 (es) 1979-10-01
DE2816608A1 (de) 1978-10-19
IE46719B1 (en) 1983-09-07
SE7803846L (sv) 1978-10-19
IT7848931A0 (it) 1978-04-17
FR2387984B1 (ja) 1980-01-18
PT67884B (en) 1980-04-07
US4162323A (en) 1979-07-24
DK150278A (da) 1979-02-08
JPS53130494A (en) 1978-11-14
NL7803623A (nl) 1978-10-20
FR2387984A1 (fr) 1978-11-17
GB1584228A (en) 1981-02-11
IT1104845B (it) 1985-10-28
PT67884A (en) 1978-05-01
CH640237A5 (de) 1983-12-30
LU79452A1 (fr) 1978-11-28

Similar Documents

Publication Publication Date Title
DK149449C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf
DK499778A (da) Fremgangsmaade til fremstilling af 9-(omegaheteroarylamino-alkylamino)-erythromyciner eller salte deraf
DK145381C (da) Fremgangsmaade til fremstilling af et antibiotisk stof,kaldet n-acetyldehydrothienamycin,eller farmaceutisk acceptable salte deraf
DK152114C (da) Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf
DK525778A (da) Fremgangsmaade til fremstilling af o-substituerede derivater af (+)-cyanidanol-3.
DK148260C (da) Analogifremgangsmaade til fremstilling af 1,3,8-trisubstituerede xantinderivater eller salte deraf
DK503080A (da) Fremgangsmaade til fremstilling af imdazolderivater eller salte deraf
DK5976A (da) Fremgangsmade til fremstilling af biphenyloxyderivater eller salte heraf
DK145504C (da) Fremgangsmaade til fremstilling af det antibiotiske stof 890a2og/eller det antibiotiske stof 890a5 og farmaceutisk acceptable salte deraf
DK392578A (da) Fremgangsmaade til fremstilling af 2-substituerede 5-hydroxy-1h-imidazol-4-carboxamidderivater eller farmaceutisk acceptble salte deraf
DK76578A (da) Fremgangsmaade til fremstilling af d,1-5-methyltetrahydrofolinsyre eller salte deraf
DK155670C (da) Analogifremgangsmaade til fremstilling af sesquiterpenderivater eller farmaceutisk acceptable salte deraf
DK158658C (da) Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK27078A (da) Fremgangsmaade til fremstilling af imidazoquinoliner eller salte deraf
DK151805C (da) Analogifremgangsmaade til fremstilling af 20,21-di-nor-eburnameninderivater eller farmaceutisk acceptable additionssalte deraf
DK232777A (da) Fremgangsmade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK511878A (da) Fremgangsmaade til fremstilling af imidazobenzoazepiner eller salte deraf
DK223177A (da) Fremgangsmade til fremstilling af p-acylaminobenzamid-forbindelser eller salte deraf
DK232677A (da) Fremgangsmade til fremstilling af dihydro eller tetrahydroiminothiaziner eller farmaceutisk acceptable salte deraf
DK127676A (da) Fremgangsmade til fremstilling af 9-alkylamino-erythromyciner eller salte deraf
DK232877A (da) Fremgangsmade til fremstilling af 2-imino-3-aminothiazolidiner eller farmaceutisk acceptable salte deraf
DK144098C (da) Fremgangsmaade til fremstilling af antibiotikum ps-5 eller salte eller estere deraf
DK150521C (da) Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk acceptable salte deraf
DK157021C (da) Analogifremgangsmaade til fremstilling af 2,3-polymethylen-4-oxo-4h-pyrido- eller -azepinooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf
DK497476A (da) Fremgangsmade til fremstilling af et antibiotisk stof

Legal Events

Date Code Title Description
PHB Application deemed withdrawn due to non-payment or other reasons